Financial Statements

Annual Reports 25-26

• Annual Report-2025-2026
• RRL ESOP Certificate 2026
• Draft RRL ESOP Scheme 2026
• Disclosure of ESOP as on 31.03.2026
• Notice of AGM 2025-2026
• Draft MGT-7_2025-26
• Form CAA-10 and Annexures-RRL and KIA
• Scheme of Merger RRL with KIA

Annual Reports 24-25

• Annual Report 2024-2025

• Rubicon Research SFS Financial Year 2022
• Rubicon Research SFS Financial Year 2023
• Rubicon Research SFS Financial Year 2024
• Rubicon Research SFS Financial Year 2025
• Rubicon Research SFS for the Quarter ended June 30, 2024
• Rubicon Research SFS for the Quarter ended June 30, 2025

• RRPL Consolidated Financial Statements FY 22
• RRPL Consolidated Financial Statements FY 23
• RRPL Consolidated Financial Statements FY 24
• RRL Consolidated Financial Statements FY 25
• RRL Consolidated Financial Statements for the Quarter ended June 30, 2024
• RRL Consolidated Financial Statements for the Quarter ended June 30, 2025

• Rubicon Subsidiary Financials FY2025-26

• AdvaGen Pharma Ltd Financial Year 2022-2024
• AdvaGen Pharma Ltd Financial Year 2025, Quarters ended June 30, 2024, and June 30, 2025

• RRCL Financial Statement FY 22
• RRCL Financial Statement FY 23
• RRCL Financial Statement FY 24
• RRCL Financial Statement FY 25
• RRCL Financial Statement for the Quarter ended June 30, 2024
• RRCL Financial Statement for the Quarter ended June 30, 2025

• RCHPL Financial Statement FY 22
• RCHPL Financial Statement FY 23
• RCHPL Financial Statement FY 24
• RCHPL Financial Statement FY 25
• RCHPL Financial Statement for the Quarter ended June 30, 2024
• RCHPL Financial Statement for the Quarter ended June 30, 2025